HJM-561 | Interleukin Related interleukin-related.com

Product Name :
HJM-561

Search keywords :
HJM-561

drugId :
null

Target Vo:
EGFR C797S

Target Vo Short Name :
EGFR C797S

Moa_Name:
EGFR C797S inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Jing Medicine Technology (Shanghai) Ltd

Active Company_Name :
Jing Medicine Technology (Shanghai) Ltd

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ERK1/2 Antibody
PRMT6 Antibody (YA685)
Retinoid X Receptor alpha Antibody: Retinoid X Receptor alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 51 kDa, targeting to Retinoid X Receptor alpha. It can be used for WB,ICC,IHC-P,IP assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts